The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Drug and Narcotic Control

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Drug and Narcotic Control


Psychiatry related information on Drug and Narcotic Control


High impact information on Drug and Narcotic Control


Chemical compound and disease context of Drug and Narcotic Control


Biological context of Drug and Narcotic Control


Anatomical context of Drug and Narcotic Control

  • In contrast to drug regulation of enzyme activity, chronic imipramine treatment did not decrease levels of TH immunoreactivity in any of the dopaminergic cell body or terminal field regions studied, although levels of TH immunoreactivity were decreased in locus coeruleus (LC) as previously reported [19].
  • Sixty seconds after the onset of seizure activity, the animals either received no drug (control) or propranolol (IV or IO via an 18-gauge spinal needle placed in the right proximal tibia) [20].

Associations of Drug and Narcotic Control with chemical compounds


Gene context of Drug and Narcotic Control


Analytical, diagnostic and therapeutic context of Drug and Narcotic Control


  1. Despite in vitro increase in cyclic guanosine monophosphate concentrations, intracarotid nitroprusside fails to augment cerebral blood flow of healthy baboons. Joshi, S., Hartl, R., Sun, L.S., Libow, A.D., Wang, M., Pile-Spellman, J., Young, W.L., Connolly, E.S., Hirshman, C.A. Anesthesiology (2003) [Pubmed]
  2. Synthesis and antimicrobial activity of some novel 2,5- and/or 6-substituted benzoxazole and benzimidazole derivatives. Oren, I., Temiz, O., Yalçin, I., Sener, E., Altanlar, N. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. (1999) [Pubmed]
  3. Trehalose-6-phosphate-potent anti-onchocerciatic agent. Oke, J.M., Watt, R.A. African journal of medicine and medical sciences. (1998) [Pubmed]
  4. Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations. Jørgensen, K.J., Johansen, H.K., Gøtzsche, P.C. Trials [electronic resource]. (2006) [Pubmed]
  5. A double-blind study comparing cefonicid with cefazolin as prophylaxis in patients undergoing total hip or knee replacement. DeBenedictis, K.J., Rowan, N.M., Boyer, B.L. Rev. Infect. Dis. (1984) [Pubmed]
  6. Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor. Lu, L., Su, W.J., Yue, W., Ge, X., Su, F., Pei, G., Ma, L. Life Sci. (2001) [Pubmed]
  7. Preventing adolescent drug abuse and high school dropout through an intensive school-based social network development program. Eggert, L.L., Thompson, E.A., Herting, J.R., Nicholas, L.J., Dicker, B.G. American journal of health promotion : AJHP. (1994) [Pubmed]
  8. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. Green, T.P., Thompson, T.R., Johnson, D.E., Lock, J.E. N. Engl. J. Med. (1983) [Pubmed]
  9. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Synold, T.W., Dussault, I., Forman, B.M. Nat. Med. (2001) [Pubmed]
  10. Drug regulation in the EEC. Doublet-Stewart, M.P. Lancet (1988) [Pubmed]
  11. Insignificant bilateral convergence of preganglionic vagal fibers on postganglionic neurons to the canine heart. Lang, S.A., Zieske, H., Levy, M.N. Circ. Res. (1990) [Pubmed]
  12. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells. Diasio, R.B., Schuetz, J.D., Wallace, H.J., Sommadossi, J.P. Cancer Res. (1985) [Pubmed]
  13. Effects of short-term treatment with coenzyme A or sulodexide on plasma lipids in patients with hypertriglyceridemia (type IV) or mixed hyperlipemia (type IIb). Ghidini, O., Zenari, L., Guilarte, N., Tessari, R., Tomba, A. International journal of clinical pharmacology, therapy, and toxicology. (1986) [Pubmed]
  14. Clinical experience with aztreonam in Germany and Austria. Stille, W., Gillissen, J. Rev. Infect. Dis. (1985) [Pubmed]
  15. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity. Conseil, G., Perez-Victoria, J.M., Jault, J.M., Gamarro, F., Goffeau, A., Hofmann, J., Di Pietro, A. Biochemistry (2001) [Pubmed]
  16. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists. Pranzatelli, M.R., Murthy, J.N., Tailor, P.T. Eur. J. Pharmacol. (1993) [Pubmed]
  17. The value of comparative bioavailability studies of marketed drugs in drug control. An example with erythromycin stearate. Venho, V.M., Palva, E.S., Konno, K., Stenfors, E. Methods and findings in experimental and clinical pharmacology. (1987) [Pubmed]
  18. Effect of intra-vas deferens injection of gossypol-polylactic acid on fertility and spermatogenesis in rats. Ye, W., Lu, G., Den, Y., Huang, Y., Xue, S. Chin. Med. Sci. J. (1993) [Pubmed]
  19. Chronic imipramine administration alters the activity and phosphorylation state of tyrosine hydroxylase in dopaminergic regions of rat brain. Rosin, D.L., Melia, K., Knorr, A.M., Nestler, E.J., Roth, R.H., Duman, R.S. Neuropsychopharmacology (1995) [Pubmed]
  20. Suppression of pentylenetetrazol-elicited seizure activity by intraosseous propranolol in pigs. Jim, K.F., Lathers, C.M., Spivey, W.H., Matthews, W.D., Kahn, C., Dolce, K. Journal of clinical pharmacology. (1988) [Pubmed]
  21. Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness. Saag, K.G., Criswell, L.A., Sems, K.M., Nettleman, M.D., Kolluri, S. Arthritis Rheum. (1996) [Pubmed]
  22. Prolonged lifespans in female NZB/NZW mice treated with the experimental immunoregulatory drug frentizole. Walker, S.E., Solsky, M., Schnitzer, B. Arthritis Rheum. (1982) [Pubmed]
  23. Use of lithium to control drug abuse. Abrahamson, J.R. The American journal of psychiatry. (1983) [Pubmed]
  24. Genetic factors in toxicology: implications for toxicological screening. Festing, M.F. Crit. Rev. Toxicol. (1987) [Pubmed]
  25. Drug control of reverse cholesterol transport. Franceschini, G., Werba, J.P., Calabresi, L. Pharmacol. Ther. (1994) [Pubmed]
  26. Effects of an orally effective endothelin-A receptor antagonist in dogs with pacing-induced heart failure. McConnell, P.I., Wang, W., Zucker, I.H. The Nebraska medical journal. (1996) [Pubmed]
  27. Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. McCoy, L., Cox, C., Richfield, E.K. Synapse (1998) [Pubmed]
  28. Targeting T cells for GVHD therapy. Vallera, D.A. Semin. Cancer Biol. (1996) [Pubmed]
  29. Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester. Xun, C.Q., Tian, Z.G., Tai, H.H. Biochem. J. (1991) [Pubmed]
  30. Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell lines. Chin, K.V., Chauhan, S.S., Abraham, I., Sampson, K.E., Krolczyk, A.J., Wong, M., Schimmer, B., Pastan, I., Gottesman, M.M. J. Cell. Physiol. (1992) [Pubmed]
  31. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. BenEzra, D., Griffin, B.W., Maftzir, G., Sharif, N.A., Clark, A.F. Invest. Ophthalmol. Vis. Sci. (1997) [Pubmed]
  32. Penetration of brodimoprim into human neutrophils and intracellular activity. Braga, P.C., Dal Sasso, M., Maci, S., Bondiolotti, G., Fonti, E., Reggio, S. Antimicrob. Agents Chemother. (1996) [Pubmed]
  33. PLG microsphere size controls drug release rate through several competing factors. Berkland, C., Kim, K., Pack, D.W. Pharm. Res. (2003) [Pubmed]
  34. Illegal drug abuse and the community camp strategy in China. Wang, W. Journal of drug education. (1999) [Pubmed]
WikiGenes - Universities